Diisopropylethylamine → HCID 178428849, compound
Reaction equation
Cl.[NH:2]1[C:7]2[N:8]=[CH:9][CH:10]=[CH:11][C:6]=2[C:5]2([CH2:16][CH2:15][NH:14][CH2:13][CH2:12]2)[O:4][C:3]1=[O:17].Cl[C:19]1[N:24]=[CH:23][N:22]=[C:21]([O:25][C:26]2[CH:39]=[C:38]([CH3:40])[C:29]3[NH:30][C:31]([CH:33]4[CH2:37][CH2:36][O:35][CH2:34]4)=[N:32][C:28]=3[CH:27]=2)[CH:20]=1.CCN(C(C)C)C(C)C.C([O-])(O)=O.[Na+]>CN(C=O)C>[CH3:40][C:38]1[C:29]2[NH:30][C:31]([CH:33]3[CH2:37][CH2:36][O:35][CH2:34]3)=[N:32][C:28]=2[CH:27]=[C:26]([O:25][C:21]2[N:22]=[CH:23][N:24]=[C:19]([N:14]3[CH2:13][CH2:12][C:5]4([O:4][C:3](=[O:17])[NH:2][C:7]5[N:8]=[CH:9][CH:10]=[CH:11][C:6]4=5)[CH2:16][CH2:15]3)[CH:20]=2)[CH:39]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
138 mg (0.54 mmol) spiro[piperidin-4,4′-pyrido[2,3-d][1,3]oxazin]-2′(1′H)-one hydrochloride, 180 mg (0.54 mmol) 5-(6-chloropyrimidin-4-yloxy)-7-methyl-2-(tetrahydrofuran-3-yl)-1H-benzo[d]imidazole and 280 μL (1.62 mmol) DIPEA in 5.0 mL DMF were stirred overnight at 60° C. The reaction mixture was combined with ice water. The precipitate formed was suction filtered and purified by chromatography. The fractions containing product were combined and evaporated down i.vac. to leave the aqueous residue. This was neutralised with an aqueous NaHCO3 solution and extracted with ethyl acetate. The organic phase was dried and evaporated down i.vac.
Workup
- customThe precipitate formed
- filtrationfiltered
- custompurified by chromatography
- additionThe fractions containing product
- customevaporated down i.vac
- customto leave the aqueous residue
- extractionextracted with ethyl acetate
- customThe organic phase was dried
- customevaporated down i.vac
Sources & evidence
- ORD record
- ord-38c0fbdd09544336a26533d33cbaf538
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08952014B2
Reaction notes
Loading…